Vivian Weiwen Xue

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Epithelial Mesenchymal Transition

Protein Protein

Transforming Growth Factor

Top Venues

Nature communications

Clinical and translational medicine

Expert opinion on drug discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Vivian Weiwen Xue, Sze Chuen Cesar Wong, Huafu Zhao, William Chi Shing Cho
Proteomic characterization of extracellular vesicles in programmed cell death. Proteomics 24 (11) (2024)
Vivian Weiwen Xue, Sze Chuen Cesar Wong, Huafu Zhao, William Chi Shing Cho
Proteomic characterization of extracellular vesicles in programmed cell death. Proteomics 24 (11) (2024)
Vivian Weiwen Xue, Sze Chuen Cesar Wong, Huafu Zhao, William Chi Shing Cho
Proteomic characterization of extracellular vesicles in programmed cell death. Proteomics (2024)
Huijun He, Yu Zhong, Honglian Wang, Patrick Ming-Kuen Tang, Vivian Weiwen Xue, Xiaocui Chen, Jiaoyi Chen, Xiaoru Huang, Cheng Wang, Hui Yao Lan
Smad3 Mediates Diabetic Dyslipidemia and Fatty Liver in db/db Mice by Targeting PPARδ. International journal of molecular sciences 24 (14) (2023)
Jeff Yat-Fai Chung, Philip Chiu-Tsun Tang, Max Kam-Kwan Chan, Vivian Weiwen Xue, Xiao-Ru Huang, Calvin Sze-Hang Ng, Dongmei Zhang, Kam-Tong Leung, Chun-Kwok Wong, Tin-Lap Lee, Eric Wing-Fai Lam, David J Nikolic-Paterson, Ka-Fai To, Hui Yao Lan, Patrick Ming-Kuen Tang
Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma. Nature communications 14 (1) (2023)
Vivian Weiwen Xue, Pinggui Lei, William Chi Shing Cho
The potential impact of ChatGPT in clinical and translational medicine. Clinical and translational medicine 13 (3) (2023)
Vivian Weiwen Xue, Sze Chuen Cesar Wong, Bo Li, William Chi Shing Cho
The discovery and development of mRNA vaccines for the prevention of SARS-CoV-2 infection. Expert opinion on drug discovery (2023)
Vivian Weiwen Xue, Pinggui Lei, William Chi Shing Cho
The potential impact of ChatGPT in clinical and translational medicine. Clinical and translational medicine 13 (3) (2023)
Jeff Yat-Fai Chung, Philip Chiu-Tsun Tang, Max Kam-Kwan Chan, Vivian Weiwen Xue, Xiao-Ru Huang, Calvin Sze-Hang Ng, Dongmei Zhang, Kam-Tong Leung, Chun-Kwok Wong, Tin-Lap Lee, Eric Wing-Fai Lam, David J Nikolic-Paterson, Ka-Fai To, Hui Yao Lan, Patrick Ming-Kuen Tang
Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma. Nature communications 14 (1) (2023)
Vivian Weiwen Xue, Sze Chuen Cesar Wong, William Chi Shing Cho
From proteomic landscape to single-cell oncoproteomics. Expert review of proteomics 18 (1) (2021)
Vivian Weiwen Xue, Chenxi Yang, Sze Chuen Cesar Wong, William Chi Shing Cho
Proteomic profiling in extracellular vesicles for cancer detection and monitoring. Proteomics 21 (13-14) (2021)
Vivian Weiwen Xue, Jeff Yat-Fai Chung, Cristina Alexandra García Córdoba, Alvin Ho-Kwan Cheung, Wei Kang, Eric W-F Lam, Kam-Tong Leung, Ka-Fai To, Hui Yao Lan, Patrick Ming-Kuen Tang
Transforming Growth Factor-β: A Multifunctional Regulator of Cancer Immunity. Cancers 12 (11) (2020)
Vivian Weiwen Xue, Sze Chuen Cesar Wong, William Chi Shing Cho
Genome-wide CRISPR screens for the identification of therapeutic targets for cancer treatment. Expert opinion on therapeutic targets 24 (11) (2020)
Vivian Weiwen Xue, Sze Chuen Cesar Wong, Guoqi Song, William Chi Shing Cho
Promising RNA-based cancer gene therapy using extracellular vesicles for drug delivery. Expert opinion on biological therapy 20 (7) (2020)